Voloridge Investment Management
DFTX

Voloridge Investment Management’s Definium Therapeutics DFTX Stock Holding History

Voloridge Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,198
Closed -$63.7K – 1296
2024
Q3 		$63.7K Sell
11,198
-15,649
-58% -$109K ﹤0.01% 1132
2024
Q2 		$194K Buy
+26,847
New +$235K ﹤0.01% 1175

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management's DFTX Position: Q4 2024 in Review

Voloridge Investment Management sold out of Definium Therapeutics (DFTX) in Q4 2024, closing a stake of 11,198 shares — an estimated $63.7K sold.

Voloridge Investment Management first reported a position in DFTX in Q2 2024 and held it in 2 quarters. The position peaked at $194K in Q2 2024. 172 funds tracked by Wall St. Rank hold DFTX as of Q4 2024.

  • Voloridge Investment Management reported no remaining Definium Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 11,198 Definium Therapeutics shares in Q4 2024, an estimated $63.7K.
  • Voloridge Investment Management first reported a position in Definium Therapeutics in Q2 2024 and held it in 2 quarters.
  • Voloridge Investment Management's Definium Therapeutics position peaked at $194K in Q2 2024.
  • 172 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.